arcitumomab 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
mouse origin 5127 154361-48-5

Description:

MoleculeDescription

Synonyms:

  • arcitumomab
  • CEA-Scan
  • IMMU-4
  • technetium Tc 99m arcitumomab
  • technetium (99mTc) arcitumomab
a commercially available IgG(1) antibody against 200-kDa CEA
  • Molecular weight:
  • Formula:
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA:
  • ALOGS:
  • ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
June 6, 2001 EMA Amgen Europe B.V.
June 28, 1996 FDA IMMUNOMEDICS
April 4, 2007 PMDA Kirin Brewery

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC V09IA06 VARIOUS
DIAGNOSTIC RADIOPHARMACEUTICALS
TUMOUR DETECTION
Technetium (99mTc) compounds

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
154361-49-6 SECONDARY_CAS_RN
D06028 KEGG_DRUG
CHEMBL1743090 ChEMBL_ID
D03651 KEGG_DRUG
C114976 MESH_SUPPLEMENTAL_RECORD_UI
C081678 MESH_SUPPLEMENTAL_RECORD_UI
DB00113 DRUGBANK_ID
DB17201 DRUGBANK_ID
230435 RXNORM
4217 MMSL
009999 NDDF
413571000 SNOMEDCT_US
415705008 SNOMEDCT_US
C0758542 UMLSCUI
CHEMBL2108253 ChEMBL_ID
7417 INN_ID
26476 PUBCHEM_CID
029JF1SCU8 UNII

Pharmaceutical products:

None